Medicine and Dentistry
Dynamic Contrast-Enhanced MRI
100%
Magnetic Resonance Imaging
95%
Osteosarcoma
78%
Neoplasm
63%
Flip Angle
40%
Event Free Survival
37%
Antiangiogenic Therapy
35%
Magnetic Resonance Imaging
34%
Fluorine-18
31%
K-Space
26%
Spectroscopic Imaging
26%
Overall Survival
26%
Parallel Imaging
26%
Cancer
26%
Pediatrics
26%
Contrast-Enhanced Ultrasound
26%
Neoadjuvant Chemotherapy
26%
Clear Cell Renal Cell Carcinoma
26%
Bevacizumab
26%
Pediatrics Patient
26%
Adjuvant Chemotherapy
26%
Myelin
26%
Prognostic Factor
26%
Adolescent
26%
Image Quality
22%
Target Lesion
19%
Leukoencephalopathy
17%
Imaging Technique
15%
Angiogenesis Inhibitor
13%
Solid Malignant Neoplasm
13%
Primary Tumor
13%
Image Reconstruction
13%
Logistic Regression Analysis
13%
Nuclear Magnetic Resonance
11%
Breathing Pattern
10%
Drug Exposure
10%
Cytotoxic Chemotherapy
10%
Positron Emission Tomography
10%
Neoadjuvant Therapy
9%
Preoperative Chemotherapy
8%
Multiple Sclerosis
8%
Non Invasive Procedure
8%
Brain Disease
8%
Spectroscopy
8%
White Matter Disease
8%
Medulla
8%
Angiogenesis
8%
Least Square Analysis
8%
Volunteer
8%
Myelination
8%
Keyphrases
Osteosarcoma
78%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
52%
Histological Response
43%
Event-free Survival
35%
Ktrans
33%
SUVmax
31%
Antiangiogenic Therapy
31%
Constrained Model
26%
18F-fluorodeoxyglucose (18F-FDG)
26%
Parallel MR Imaging
26%
Young Adult Patients
26%
Overall Survival
26%
FDG Uptake
26%
Cascaded Convolutional Neural Network
26%
Prognostic Factors
26%
Quantitative Reconstruction
26%
Truncated Projection
26%
Fast Frequency Sweep
26%
Bevacizumab
26%
Solid Malignancies
26%
Carotid Artery Imaging
26%
Pediatric Patients
26%
Pediatric
26%
Adjuvant Chemotherapy
26%
Neoadjuvant Chemotherapy
26%
Contrast-enhanced Ultrasound
26%
Polydisulfide
26%
Parameter Independent
26%
Vascular Effects
26%
Reduced FOV
26%
Peak Enhancement
19%
Target Lesion
19%
IAUC
19%
Tumor
19%
Time to Progression
19%
Cascaded Network
17%
Few-shot
17%
3D Data Augmentation
17%
Convolution Neural Network Model
17%
Newly Diagnosed
13%
K Parameter
13%
Model Predictive Controller
13%
Reconstruction Coefficient
13%
Non-negative Least Squares Algorithm
13%
Solid Tumors
13%
Change from Baseline
10%
Minimum Cost Path
10%
Drug Exposure
10%
Image Quality Metrics
10%
Cytotoxic Therapy
10%